Advantages of OCT

Article

According to Professor Albert Augustin, OCT is mandatory in research and very helpful in avoiding unnecessary treatment.

According to Professor Albert Augustin, OCT is mandatory in research and very helpful in avoiding unnecessary treatment. He described his viewpoint in this month's cover feature on retina imaging.

"One of the major advantages of SD-OCT is the ability to create 3D samples of the tissue…" Prof. Augustin said. This enables more insight and better understanding as much more detail can be seen.

Not only can OCT technology assist in a surgeons preoperative judgement of a patient but it can also help with the decision on treatment regimen. In planning surgery a physician can use SD-OCT to perform a correct prognosis on a patient as it will allow them to view any alterations occurring, for example, in the RPE. Once the correct prognosis has been made then the level of detail gained form an OCT image can be used to guide the practitioner to the appropriate procedure.

Surgical follow-up of a patient can also benefit from OCT. In cases of retinal vein occlusion it is possible to view bright reflective dots that are inflammatory markers that should react on the implantation of dexamethasone slow release devices. "Differences in the numbers of these dots can be assessed by OCT during the follow up of a RVO patient," said Prof. Augustin.

OCT is interesting in research and clinical follow up in Prof. Augustin's opinion. However, he stressed that in cases of AMD OCT is mandatory and the images must be viewed carefully. It is simple to misinterpret results leading to an incorrect diagnosis and mistreatment of patients.

In conclusion, Prof. Augustin said, "I would like to encourage the use of OCT, especially in macular disesases."

If you would like to read more about the advantages of OCT, see Prof. Augustin's full article in the May print issue of OTEurope.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
© 2025 MJH Life Sciences

All rights reserved.